Resources

The latest in drug discovery, from novel targets and screening tools through to automation and computational chemistry

Organ Modelling Discovery

FDA Can Deem Animal Testing of Drugs No Longer Necessary

For the first time since 1938, the FDA will no longer require animal modelling for drugs to enter clinical trials after a new Act is passed.
Organ Modelling Discovery

Lab on a Chip

A deep conical agarose microwell array for adhesion independent three-dimensional cell culture and dynamic volume measurement
Pharma Data

FAIR Principles for Use: The Harmonisation and Standardisation of Data through FAIRification

The biggest focus for those in the pharmaceuticals industry moving forward should be to emphasise the importance of proactive adaptability in implementing FAIR data frameworks, and to underscore how making the investment now will pay dividends in years to come.
Target Based Discovery

Target Identification, Phenotypic and Cell-based Screening

Oxford Global’s discussion group brings together specialists in target identification, phenotypic, and cell-based screening
Pharma Data

Why Dream of Lab Instrument Connectivity When it’s Right at Your Fingertips

Digitalisation is the reality for each of us in our private life. In laboratories, it’s still a dream. But why are we dreaming of digitalisation and of connectivity between your instruments and your leading systems when these things are actually at our fingertips? The reason might be obvious: when the right tools to connect all software silos are missing, we can’t be digitalised in reality.
Neuroscience Discovery

Light Powered Neural Propagation Assay

Synaptic connections are a fundamental building block of neuronal function, enabling the propagation of activity from one neuronal circuit to another
Pharma Data

Synthetic Data: Democratising Data Access to Improve Patient Outcomes

In this Commentary article, we explore some of the applications of synthetic data generation in the context of healthcare and treatment. Synthetic data can overcome problems surrounding privacy and enable the sharing of important medical information without compromising the privacy of patients.
Pharma Data

Digital Health & Technology: Barriers to Adoption

Digital health is often seen as the 'next big thing' but there are challenges ahead. This month, our discussion group focused on fragmentation, data flow, protection and regulatory approval.
Pharma Data

Knowledge Graphs Fuel Drug Discovery: How AstraZeneca Uses Neo4j

On-Demand Webinar featuring Dr Christos Kannas, Associate Principal Scientist at R&D AstraZeneca & Dr Maya Natarajn, Neo4j Senior Director of Knowledge Graphs
Neuroscience Discovery

Challenges in Translational Approaches and Biomarkers in Neurodegeneration

Identifying disease targets, understanding complex biology, and developing effective technologies for target engagement.
Neuroscience Discovery

Axion: Neural Activity Assay

In vitro neural models are a proven powerful strategy for the study of neural function and complex disorders of the human nervous system.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things discovery